Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).
Consumers Should Be Ready For Further Price Increases, Nestle’s Chief Executive Says
Nestle SA's (OTC: NSRGY) (OTC: NSRGF) Chief Executive Officer Mark Schneider said inflation will remain an issue in 2023.
Nestle Bets €40M On Enterome’s Preclinical Food Allergy, IBD Hopeful
France-based Enterome signed a strategic R&D collaboration and license agreement with Nestlé SA’s (OTC:NSRGF) Health Science, targeting food allergies and inflammatory bowel disease…
Dada Nexus, Nestlé Expand Partnership To Boost Omni-Channel Growth
Dada Nexus Ltd (NASDAQ:DADA) and Nestle SA‘s (OTC:NSRGF) Nestle (China) Co Ltd have expanded their partnership for omnichannel marketing and digitalization. The…
More Mixed Earnings From CPG Companies — The Stockout
With all the current disruptions happening in container shipping, many shippers are trying to think through how they can position themselves long-term to access capacity. One of the strategies that are becoming popular is to sign multi-year agreements with your carrier partners.
Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
Seres Therapeutics Inc (NASDAQ: MCRB) has inked a $525-million deal with Nestlé Health Science to commercialize SER-109 if it can win FDA approval. SER-109…